Research gaps in psoriasis: Opportunities for future studies

被引:91
作者
Ryan, Caitriona [1 ]
Korman, Neil J. [2 ]
Gelfand, Joel M. [3 ,4 ]
Lim, Henry W. [5 ]
Elmets, Craig A. [6 ]
Feldman, Steven R. [7 ]
Gottlieb, Alice B. [8 ]
Koo, John Y. M. [9 ]
Lebwohl, Mark [10 ]
Leonardi, Craig L. [11 ]
Van Voorhees, Abby S. [3 ]
Bhushan, Reva [12 ]
Menter, Alan [1 ]
机构
[1] Baylor Univ, Med Ctr, Psoriasis Res Ctr, Dallas, TX USA
[2] Univ Hosp Case Med Ctr, Murdough Family Ctr Psoriasis, Dept Dermatol, Cleveland, OH USA
[3] Univ Penn, Dept Dermatol, Detroit, MI USA
[4] Univ Penn, Ctr Clin Epidemiol & Biostat, Detroit, MI USA
[5] Henry Ford Hosp, Dept Dermatol, Detroit, MI 48202 USA
[6] Univ Alabama Birmingham, Dept Dermatol, Birmingham, AL 35294 USA
[7] Wake Forest Univ, Sch Med, Dept Dermatol, Winston Salem, NC 27109 USA
[8] Tufts Univ, Sch Med, Tufts Med Ctr, Boston, MA 02111 USA
[9] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA
[10] Mt Sinai Sch Med, Dept Dermatol, New York, NY USA
[11] St Louis Univ, Schaumburg, IL USA
[12] Amer Acad Dermatol, Schaumburg, IL 60173 USA
关键词
adjunctive therapies; biologics; cardiovascular disease; comorbidities in psoriasis; comparative studies; disease severity; environmental factors in the development of psoriasis; future research studies; methotrexate; molecular studies in psoriatic and psoriatic arthritis; pathomechanisms and genetics of psoriasis; phototherapy; psoriasis; psoriasis guidelines; psoriasis treatment; psoriatic arthritis; psychological; research gaps; therapeutic targets; topical therapies; QUALITY-OF-LIFE; CORTICOTROPIN-RELEASING HORMONE; ENDOTHELIAL GROWTH-FACTOR; CHRONIC PLAQUE PSORIASIS; GENOME-WIDE ASSOCIATION; NECROSIS-FACTOR ANTAGONISTS; HIGH-NEED PATIENTS; T-CELLS; RISK-FACTORS; CARDIOVASCULAR EVENTS;
D O I
10.1016/j.jaad.2013.08.042
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Over the past 2 decades, considerable progress has been made to further elucidate the complex pathogenesis of psoriasis, facilitating the development of a new armamentarium of more effective, targeted therapies. Despite these important advances, substantial deficits remain in our understanding of psoriasis and its treatment, necessitating further research in many areas. In the sixth section of the American Academy of Dermatology Psoriasis Guidelines of Care, gaps in research and care were identified. We discuss the most important gaps in research that currently exist and make suggestions for studies that should be performed to address these deficits. These encompass both basic science and clinical research studies, including large, prospective epidemiologic studies to determine the true prevalence and natural history of psoriasis; further molecular studies in patients with psoriatic and psoriatic arthritis to understand the function of psoriasis susceptibility genes and to identify novel therapeutic targets; studies to examine the role of environmental factors in the development of psoriasis; further investigation of the relationship between psoriasis and cardiometabolic disease; studies that examine the role of adjunctive therapies such as psychological interventions in appropriate patient groups; and finally, studies to identify biomarkers of disease severity and treatment response to optimize patient therapy.
引用
收藏
页码:146 / 167
页数:22
相关论文
共 193 条
[1]   Complete remission of psoriasis following bevacizumab therapy for colon cancer [J].
Akman, A. ;
Yilmaz, E. ;
Mutlu, H. ;
Ozdogan, M. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (05) :E202-E204
[2]  
Andrulonis R, 2012, J DRUGS DERMATOL, V11, P1240
[3]   Angiogenesis and oxidative stress: Common mechanisms linking psoriasis with atherosclerosis [J].
Armstrong, April W. ;
Voyles, Stephanie V. ;
Armstrong, Ehrin J. ;
Fuller, Erin N. ;
Rutledge, John C. .
JOURNAL OF DERMATOLOGICAL SCIENCE, 2011, 63 (01) :1-9
[4]   Increased Risk of Diabetes Mellitus and Likelihood of Receiving Diabetes Mellitus Treatment in Patients With Psoriasis [J].
Azfar, Rahat S. ;
Seminara, Nicole M. ;
Shin, Daniel B. ;
Troxel, Andrea B. ;
Margolis, David J. ;
Gelfand, Joel M. .
ARCHIVES OF DERMATOLOGY, 2012, 148 (09) :995-1000
[5]   Review of treatment options for psoriasis in pregnant or lactating women: From the Medical Board of the National Psoriasis Foundation [J].
Bae, Yoon-Soo Cindy ;
Van Voorhees, Abby S. ;
Hsu, Sylvia ;
Korman, Neil J. ;
Lebwohl, Mark G. ;
Young, Melody ;
Bebo, Bruce, Jr. ;
Kimball, Alexa Boer .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2012, 67 (03) :459-477
[6]   Pregnancy outcome after cyclosporine therapy during pregnancy: A meta-analysis [J].
Bar-Oz, B ;
Hackman, R ;
Einarson, T ;
Koren, G .
TRANSPLANTATION, 2001, 71 (08) :1051-1055
[7]   Infliximab plus methotrexate is superior to methotrexate alone in the treatment of psoriatic arthritis in methotrexate-naive patients: the RESPOND study [J].
Baranauskaite, Asta ;
Raffayova, Helena ;
Kungurov, N. V. ;
Kubanova, Anna ;
Venalis, Algirdas ;
Helmle, Laszlo ;
Srinivasan, Shankar ;
Nasonov, Evgeny ;
Vastesaeger, Nathan .
ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (04) :541-548
[8]  
Behnam Shahrad M, 2005, Skinmed, V4, P174
[9]  
Ben-David G, 2008, J REPROD MED, V53, P183
[10]   Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding [J].
Berthelsen, Birgitte G. ;
Fjeldsoe-Nielsen, Hans ;
Nielsen, Christoffer T. ;
Hellmuth, Ellinor .
RHEUMATOLOGY, 2010, 49 (11) :2225-2227